|
|
Imperial BioIncubator, Bessemer Building (RSM), Prince Consort Road
London, SW7 2BP United Kingdom
phone:(44) (0) 207 594 1059
fax:(44) (0) 207 594 1070
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.thiakis.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Treatment of obesity and other metabolic diseases. |
|
| Management |
| Dr John Burt, Chief Executive Officer; Professor Steve Bloom, Chief Scientific Officer; Dr Martin Edwards, Novo A/S; non-executive director; Dr Mike Hayes, non-executive director; Dr Raj Parekh, Advent Venture Partners; non-executive director; Susan Searle, Imperial Innovations; non-executive director |
| |
|
|
| |
|
| Keywords |
| obesity, metabolic, gut, hormoes, appetite, oxyntomodulin, peptide |
|
|
|
| Description |
|
Thiakis is a privately owned biopharmaceutical company focused on the development of novel therapeutic approaches for the treatment of obesity and other metabolic diseases. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members